ArticleResearch square2026
Deep-learning-derived glaucoma-related endophenotypes enable novel genome-wide genetic and functional discovery.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The genetic architecture of primary open-angle glaucoma (POAG), a leading cause of irreversible blindness, remains largely unexplained due to the reliance of previous genome-wide association studies (GWAS) on imprecise phenotypes from electronic health records. Here, we overcome this with a disease-trained, task-transfer machine learning (ML) framework that learns glaucoma-related damage patterns from a large clinical repository of 8,323 glaucoma patients. We showed that ML optical coherence tomography (OCT)-derived endophenotypes trained on 18,985 OCT scans from these patients identified novel loci associated with POAG. By applying the derived endophenotypes to 47,908 UK Biobank participants, we performed GWAS in European, African, and Asian ancestral groups followed by cross-ancestry meta-analyses. In total, we identified 36 and 43 LD-independent GWAS loci that passed genome-wide significance in the EUR and cross-ancestry meta-analysis, respectively. About two thirds of the identified loci overlapped with previously reported POAG related associations, demonstrating the validity of our approach. Importantly, more than a third (21) of the loci were novel to glaucoma. Extensive functional analyses, including Bayesian colocalization analysis, gene-based association tests, Mendelian randomization, and single-cell enrichment analysis, converged on 11 high-confidence gene effectors, five of which were novel to glaucoma. These genes support Wnt-mediated outflow dysfunction and retinal ganglion cell vulnerability in POAG pathogenesis and are potential actionable drug targets. Our findings expanded POAG genetic associations, provided mechanistic insights at cell-type resolution, and proposed plausible putative causal genes. This study provides a powerful, generalizable ML-driven strategy for accelerating the discovery of disease mechanisms and therapeutic targets for complex diseases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.